Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2011-10-26
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00807885
- Locations
- 🇺🇸
MDS Pharma Services, Neptune, New Jersey, United States
Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-08
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT00804453
- Locations
- 🇫🇷
AURAL, Bourgoin Jallieu, France
Reduction of Heparin Dose in Dialysis With Evodial System
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 53
- Registration Number
- NCT00781690
- Locations
- 🇸🇪
Karolinska Hospital, Stockholm, Sweden
🇫🇷Hopital Brabois, Vandoeuvre les Nancy, France
🇫🇷Clinique St Exupéry, Toulouse, France
Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 216
- Registration Number
- NCT00762372
- Locations
- 🇯🇵
Tokyo University, Tokyo, Japan
🇯🇵Keio University, Tokyo, Japan
🇯🇵Okayama University, Okayama, Japan
Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 45
- Registration Number
- NCT00708071
Fibrin Sealant for the Sealing of Dura Sutures
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2013-06-27
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 95
- Registration Number
- NCT00681824
Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer
Completed
- Conditions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT00659724
- Locations
- 🇺🇸
Advanced Dialysis Center of Easton, Easton, Maryland, United States
🇺🇸Advanced Dialysis Center of Potomac, Arlington, Virginia, United States
Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT00636077
- Locations
- 🇺🇸
University of Louisville, Kidney Disease Program, Louisville, Kentucky, United States
Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT00636389
- Locations
- 🇺🇸
DaVita Clinical Research Facility, Minneapolis, Minnesota, United States
Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 69
- Registration Number
- NCT00621114
- Locations
- 🇩🇪
Universitaetsklinikum Tuebingen, Tuebingen, Germany
© Copyright 2024. All Rights Reserved by MedPath